Cambridge Trust CO Merck & Co., Inc. Transaction History

Cambridge Trust CO

  • $2.6 Billion
  • Q1 2024

A detailed history of Cambridge Trust CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cambridge Trust CO holds 338,060 shares of MRK stock, worth $38.4 Million. This represents 1.72% of its overall portfolio holdings.

Number of Shares
338,060
Previous 235,718 43.42%
Holding current value
$38.4 Million
Previous $25.7 Million 73.59%
% of portfolio
1.72%
Previous 1.09%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 30, 2024
BUY
$113.24 - $131.95 $11.6 Million - $13.5 Million
102,342 Added 43.42%
338,060 $44.6 Million
Q4 2023

Jan 31, 2024
SELL
$100.18 - $109.02 $26,748 - $29,108
-267 Reduced 0.11%
235,718 $25.7 Million
Q3 2023

Oct 26, 2023
BUY
$102.95 - $114.33 $361,972 - $401,984
3,516 Added 1.51%
235,985 $24.3 Million
Q2 2023

Jul 25, 2023
SELL
$108.61 - $118.38 $392,407 - $427,706
-3,613 Reduced 1.53%
232,469 $26.8 Million
Q1 2023

May 12, 2023
SELL
$102.94 - $114.86 $1.91 Million - $2.13 Million
-18,520 Reduced 7.27%
236,082 $25.1 Million
Q4 2022

Jan 09, 2023
SELL
$87.44 - $112.11 $370,920 - $475,570
-4,242 Reduced 1.64%
254,602 $28.2 Million
Q3 2022

Nov 07, 2022
BUY
$84.53 - $94.96 $1.09 Million - $1.23 Million
12,945 Added 5.26%
258,844 $22.3 Million
Q2 2022

Aug 16, 2022
BUY
$83.49 - $94.64 $1.66 Million - $1.88 Million
19,827 Added 8.77%
245,899 $22.4 Million
Q1 2022

May 12, 2022
BUY
$73.51 - $82.4 $641,301 - $718,857
8,724 Added 4.01%
226,072 $18.5 Million
Q4 2021

Feb 14, 2022
BUY
$72.28 - $90.54 $1.43 Million - $1.79 Million
19,811 Added 10.03%
217,348 $16.7 Million
Q3 2021

Nov 23, 2021
BUY
$71.68 - $78.83 $462,336 - $508,453
6,450 Added 3.38%
197,537 $14.8 Million
Q3 2021

Nov 16, 2021
SELL
$71.68 - $78.83 $742,031 - $816,048
-10,352 Reduced 5.14%
191,087 $14.4 Million
Q2 2021

Aug 16, 2021
SELL
$70.31 - $77.77 $717,865 - $794,031
-10,210 Reduced 4.82%
201,439 $15.7 Million
Q1 2021

May 14, 2021
SELL
$68.86 - $81.11 $20.6 Million - $24.3 Million
-299,859 Reduced 58.62%
211,649 $16.3 Million
Q4 2020

Jan 27, 2021
BUY
$71.77 - $79.65 $1.05 Million - $1.17 Million
14,655 Added 2.95%
511,508 $41.8 Million
Q3 2020

Nov 03, 2020
BUY
$73.18 - $82.95 $18,734 - $21,235
256 Added 0.05%
496,853 $41.2 Million
Q2 2020

Aug 05, 2020
BUY
$70.42 - $80.13 $104,644 - $119,073
1,486 Added 0.3%
496,597 $40.6 Million
Q1 2020

May 04, 2020
BUY
$63.36 - $87.82 $392,705 - $544,308
6,198 Added 1.27%
495,111 $38.1 Million
Q4 2019

Feb 04, 2020
BUY
$77.58 - $87.54 $95,345 - $107,586
1,229 Added 0.25%
488,913 $44.5 Million
Q3 2019

Nov 06, 2019
SELL
$76.08 - $82.93 $245,890 - $268,029
-3,232 Reduced 0.66%
487,684 $41.1 Million
Q2 2019

Jul 29, 2019
SELL
$69.84 - $81.59 $166,428 - $194,428
-2,383 Reduced 0.48%
490,916 $0
Q1 2019

Apr 22, 2019
SELL
$69.58 - $79.36 $1.24 Million - $1.41 Million
-17,819 Reduced 3.49%
493,299 $41 Million
Q4 2018

Feb 04, 2019
SELL
$65.24 - $75.71 $243,475 - $282,549
-3,732 Reduced 0.72%
511,118 $39.1 Million
Q3 2018

Oct 22, 2018
BUY
$57.69 - $67.84 $71,420 - $83,985
1,238 Added 0.24%
514,850 $36.5 Million
Q2 2018

Aug 06, 2018
SELL
$50.83 - $59.72 $331,157 - $389,075
-6,515 Reduced 1.25%
513,612 $31.2 Million
Q1 2018

Apr 27, 2018
SELL
$50.96 - $59.23 $470,819 - $547,225
-9,239 Reduced 1.75%
520,127 $28.3 Million
Q4 2017

Jan 24, 2018
SELL
$51.62 - $61.64 $1.48 Million - $1.77 Million
-28,658 Reduced 5.14%
529,366 $0
Q3 2017

Nov 02, 2017
BUY
$58.67 - $63.13 $32.7 Million - $35.2 Million
558,024
558,024 $0

Others Institutions Holding MRK

# of Institutions
3,830
Shares Held
1.91B
Call Options Held
13.4M
Put Options Held
10.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $288B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Cambridge Trust CO Portfolio

Follow Cambridge Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email